Hui Chen

机构：Sun Yat-sen University, Peking University, Peking University Cancer Hospital, Fourth People’s Hospital of Jinan, Xi'an Medical University, Fifth Affiliated Hospital of Sun Yat-sen University, Jinan Third People's Hospital, Air Force Medical University · ORCID：0000-0001-6558-3460

发表论文 78 篇 · 总被引 1678 次 · h-index 18

代表论文

• A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy (2023 · Translational Oncology · 被引 12)
• Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma (2024 · Journal of Hepatocellular Carcinoma · 被引 7)
• Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis (2024 · The American Surgeon · 被引 6)
• Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis (2025 · HepatoBiliary Surgery and Nutrition · 被引 2)
• High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy (2024 · International Immunopharmacology · 被引 2)
• Efficacy and safety of irinotecan-eluting HepaSphere transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for unresectable colorectal liver metastases. (2023 · Journal of Clinical Oncology · 被引 2)